SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shilpi Saha, Shravanti Mukherjee, Minakshi Mazumdar, Argha Manna, Poulami Khan, Arghya Adhikary, Kirti Kajal, Debarshi Jana, Gaurisankar Sa, Sanhita Mukherjee, Diptendra K. Sarkar, Tanya Das, Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin, Translational Research, 2015, 165, 5, 558

    CrossRef

  2. 2
    Yuanyuan Zhao, Fei Chen, Yuanming Pan, Zhipeng Li, Xiangdong Xue, Chukwunweike Ikechukwu Okeke, Yifeng Wang, Chan Li, Ling Peng, Paul C. Wang, Xiaowei Ma, Xing-Jie Liang, Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance, ACS Applied Materials & Interfaces, 2015, 150819152556009

    CrossRef

  3. 3
    Amadeo M. Parissenti, Baoqing Guo, Laura B. Pritzker, Kenneth P. H. Pritzker, Xiaohui Wang, Mu Zhu, Lois E. Shepherd, Maureen E. Trudeau, Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy, Breast Cancer Research and Treatment, 2015, 153, 1, 135

    CrossRef

  4. 4
    Tun-Chieh Chen, Ya-Ling Hsu, Yu-Chieh Tsai, Yu-Wei Chang, Po-Lin Kuo, Yen-Hsu Chen, Gemifloxacin inhibits migration and invasion and induces mesenchymal–epithelial transition in human breast adenocarcinoma cells, Journal of Molecular Medicine, 2014, 92, 1, 53

    CrossRef

  5. 5
    Julie C. Friedland, Donald L. Smith, Jim Sang, Jaime Acquaviva, Suqin He, Chaohua Zhang, David A. Proia, Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes, Investigational New Drugs, 2014, 32, 1, 14

    CrossRef

  6. 6
    Jens Huober, Gunter von Minckwitz, Neoadjuvant Therapy – What Have We Achieved in the Last 20 Years, Breast Care, 2011, 6, 6, 419

    CrossRef

  7. 7
    J.-S. Frénel, M. Campone, Chimiothérapie des cancers du sein non métastatiques : état des lieux en 2010, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2010, 39, 8, F79

    CrossRef